US generic drug maker Mylan said Monday it would distribute in India two Gilead drugs for chronic hepatitis C, including its blockbuster Sovaldi treatment for the liver disease. Mylan Pharmaceuticals said its Indian subsidiary, Mylan Pharmaceuticals Private Limited, has received exclusive rights to distribute the branded medicines Sovaldi and Harvoni in the country. India last month became the first country in Asia to approve Sovaldi, and distribution of the branded drug is set to begin in the second quarter this year, Mylan said.
via Health News Headlines - Yahoo News http://ift.tt/1BeU7Ev
No comments:
Post a Comment